Dosing and Administration Guide - NATPARA

← Back to document page

Study details: A 24-week, randomized, multinational, double-blind, placebo-controlled phase 3 trial evaluated the efficacy and safety of NATPARA in 124 adults with hypoparathyroidism after an optimization period of up

  Administration, Guide, Details, Dosing, Dosing and administration guide